Neurogene, Inc. (NGNE)
28.31
-2.94
(-9.41%)
USD |
NASDAQ |
Sep 25, 16:00
28.32
+0.01
(+0.04%)
After-Hours: 19:59
Neurogene Total Assets (Quarterly) : 244.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 244.36M |
| March 31, 2026 | 263.14M |
| December 31, 2025 | 289.18M |
| September 30, 2025 | 287.83M |
| June 30, 2025 | 297.32M |
| March 31, 2025 | 315.30M |
| December 31, 2024 | 336.44M |
| September 30, 2024 | 164.12M |
| June 30, 2024 | 179.82M |
| March 31, 2024 | 195.35M |
| December 31, 2023 | 222.57M |
| September 30, 2023 | 89.59M |
| June 30, 2023 | 94.00M |
| March 31, 2023 | 98.46M |
| December 31, 2022 | 109.26M |
| September 30, 2022 | 126.58M |
| June 30, 2022 | 137.02M |
| March 31, 2022 | 149.13M |
| December 31, 2021 | 163.26M |
| September 30, 2021 | 175.93M |
| June 30, 2021 | 187.02M |
| March 31, 2021 | 200.10M |
| December 31, 2020 | 210.52M |
| September 30, 2020 | 221.69M |
| June 30, 2020 | 145.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 153.05M |
| December 31, 2019 | 147.02M |
| September 30, 2019 | 69.79M |
| June 30, 2019 | 73.74M |
| March 31, 2019 | 75.43M |
| December 31, 2018 | 77.62M |
| September 30, 2018 | 87.81M |
| June 30, 2018 | 104.43M |
| March 31, 2018 | 95.62M |
| December 31, 2017 | 110.33M |
| September 30, 2017 | 121.60M |
| June 30, 2017 | 133.28M |
| March 31, 2017 | 143.33M |
| December 31, 2016 | 154.38M |
| September 30, 2016 | 164.07M |
| June 30, 2016 | 100.70M |
| March 31, 2016 | 108.21M |
| December 31, 2015 | 113.34M |
| September 30, 2015 | 118.03M |
| June 30, 2015 | 29.86M |
| March 31, 2015 | 35.13M |
| December 31, 2014 | 41.42M |
| September 30, 2014 | 48.62M |
| June 30, 2014 | 52.96M |
| March 31, 2014 | 56.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.23M |
| Shareholders Equity (Quarterly) | 217.13M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 10.63 |
| Net Debt Paydown Yield | 0.14% |